Due in part to increasing rates of obesity, another major risk factor is emerging, metabolic dysfunction-associated steatotic ...

Altimmune, Inc.’s Pemvidutide shows promise as a dual-action treatment for obesity and MASLD/MASH, targeting weight loss, ...

The prevalence of liver steatosis was higher in people living with HIV compared with liver fibrosis, although both liver ...

Discover a new study that has examined the influence of clinical and histologic risk factors on long-term MASLD outcomes in ...

Find Fatty Liver Diseases Latest News, Videos & Pictures on Fatty Liver Diseases and see latest updates, news, information ...

MASLD diagnosis was associated with an increased risk for youth-onset type 2 diabetes among pediatric patients with obesity.

The study, published in the Journal of Hepatology Reports, showed that low-medium fat dairy products may be protective, and ...

A recent study highlights the potential benefits of oral semaglutide in managing type 2 diabetes mellitus (T2DM) for patients ...

The success surrounding the medications for obesity and diabetes has sparked research into whether they could also be an ...

Liver fibrosis is a progressive and potentially reversible condition that results from chronic liver damage, which can be ...

Children with obesity and metabolic dysfunction–associated steatotic liver disease (MASLD) have a higher risk for youth-onset type 2 diabetes (T2D), and the risk increases dramatically in the ...

Liver diseases are any diseases that affect the functioning of the liver. Liver diseases can be inherited (such as Wilson disease and alpha 1-antitrypsin deficiency) or acquired (for example ...